|
Volumn 67, Issue 2, 2015, Pages 582-583
|
Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
LEFLUNOMIDE;
MESALAZINE;
METHOTREXATE;
NEUTRALIZING ANTIBODY;
PREDNISONE;
RITUXIMAB;
SALAZOSULFAPYRIDINE;
YELLOW FEVER VACCINE;
ANTIRHEUMATIC AGENT;
IMMUNOLOGIC FACTOR;
ISOXAZOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
ADOLESCENT;
ADULT;
AGED;
ARTHRALGIA;
CHILD;
CLINICAL ARTICLE;
DRUG FEVER;
FEMALE;
HUMAN;
MYALGIA;
NOTE;
PRIORITY JOURNAL;
REVACCINATION;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
RHINORRHEA;
SEROCONVERSION;
YELLOW FEVER;
ADVERSE EFFECTS;
ARTHRITIS, RHEUMATOID;
BLOOD;
BRAZIL;
CONTRAINDICATIONS;
DRUG EFFECTS;
IMMUNIZATION;
IMMUNOLOGY;
INNATE IMMUNITY;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MIDDLE AGED;
RETROSPECTIVE STUDY;
RHEUMATIC DISEASES;
SCLERODERMA, SYSTEMIC;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
BRAZIL;
CHILD;
FEMALE;
HUMANS;
IMMUNITY, INNATE;
IMMUNIZATION, SECONDARY;
IMMUNOLOGIC FACTORS;
IMMUNOSUPPRESSIVE AGENTS;
ISOXAZOLES;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RHEUMATIC DISEASES;
SCLERODERMA, SYSTEMIC;
YELLOW FEVER;
YELLOW FEVER VACCINE;
YOUNG ADULT;
|
EID: 84922791598
PISSN: 23265191
EISSN: 23265205
Source Type: Journal
DOI: 10.1002/art.38960 Document Type: Note |
Times cited : (31)
|
References (3)
|